UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group

Journal of clinical oncology, 2010-10, Vol.28 (30), p.4658-4663

2010

Volltextzugriff (PDF)

Rhabdomyosarcoma: New Windows of Opportunity

The oncologist (Dayton, Ohio), 2005-08, Vol.10 (7), p.518-527

2005

Volltextzugriff (PDF)

Factors Associated with Failure of Oncology Drugs in Late-Stage Clinical Development: a Systematic Review

Cancer treatment reviews, 2017-01, Vol.52, p.12-21

2017

Volltextzugriff (PDF)

Assessment of Response to Induction Therapy and Its Influence on 5-Year Failure-Free Survival in Group III Rhabdomyosarcoma: The Intergroup Rhabdomyosarcoma Study-IV Experience—A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Journal of clinical oncology, 2007-11, Vol.25 (31), p.4909-4913

2007

Volltextzugriff (PDF)

Pooled Analysis of Phase II Window Studies in Children With Contemporary High-Risk Metastatic Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Journal of clinical oncology, 2006-07, Vol.24 (21), p.3415-3422

2006

Volltextzugriff (PDF)

End points to establish the efficacy of new agents in the treatment of acute leukemia

Blood, 2007-03, Vol.109 (5), p.1810-1816

2007

Volltextzugriff (PDF)

Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma

Modern pathology, 2006-09, Vol.19 (9), p.1213-1220

2006

Volltextzugriff (PDF)

DOES BLADDER PRESERVATION (AS A SURGICAL PRINCIPLE) LEAD TO RETAINING BLADDER FUNCTION IN BLADDER/PROSTATE RHABDOMYOSARCOMA? RESULTS FROM INTERGROUP RHABDOMYOSARCOMA STUDY IV

The Journal of urology, 2004-06, Vol.171 (6), p.2396-2403

2004

Volltextzugriff (PDF)

Risk‐based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group

Cancer, 2019-08, Vol.125 (15), p.2602-2609

2019

Volltextzugriff (PDF)

Efficacy of Topotecan and Cyclophosphamide Given in a Phase II Window Trial in Children With Newly Diagnosed Metastatic Rhabdomyosarcoma: A Children’s Oncology Group Study

Journal of clinical oncology, 2004-04, Vol.22 (8), p.1398-1403

2004

Volltextzugriff (PDF)

Examination of Gene Fusion Status in Archival Samples of Alveolar Rhabdomyosarcoma Entered on the Intergroup Rhabdomyosarcoma Study-III Trial: A Report from the Children's Oncology Group

The Journal of molecular diagnostics : JMD, 2006-05, Vol.8 (2), p.202-208

2006

Volltextzugriff (PDF)

Belief in home chemotherapy

Pediatric blood & cancer, 2006-09, Vol.47 (3), p.237-238

Breitfeld, Philip P.

2006

Volltextzugriff (PDF)

Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma children's cancer group (CCG) 7943

Cancer, 2007-04, Vol.109 (8), p.1646-1653

2007

Volltextzugriff (PDF)

Hospital resource utilization in childhood cancer

Journal of pediatric hematology/oncology, 2005-06, Vol.27 (6), p.295-300

2005

Volltextzugriff (PDF)

Early Introduction of an Evidence‐based Medicine Course to Preclinical Medical Students

Journal of general internal medicine : JGIM, 2002-01, Vol.17 (1), p.58-65

2002

Volltextzugriff (PDF)

Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma

Journal of pediatric hematology/oncology, 2001-06, Vol.23 (5), p.272-276

2001

Volltextzugriff (PDF)

Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group

Journal of pediatric hematology/oncology, 2001-05, Vol.23 (4), p.225-233

2001

Volltextzugriff (PDF)

Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia

Journal of pediatric hematology/oncology, 2002-05, Vol.24 (4), p.256-262

2002

Volltextzugriff (PDF)

Assessing the overall impact of therapy: it's not so simple

Journal of pediatric hematology/oncology, 2002-10, Vol.24 (7), p.518-520

Breitfeld, Philip P

2002

Volltextzugriff (PDF)

Phosphorylation of the Polymeric Immunoglobulin Receptor Required for Its Efficient Transcytosis

Science (American Association for the Advancement of Science), 1990-05, Vol.248 (4956), p.742-745

1990

Volltextzugriff (PDF)

Accurate case finding using linked electronic clinical and administrative data at a children's hospital

Journal of clinical epidemiology, 2001-10, Vol.54 (10), p.1037-1045

2001

Volltextzugriff (PDF)

Modeling administrative outcomes in fever and neutropenia: clinical variables significantly influence length of stay and hospital charges

Journal of pediatric hematology/oncology, 2002-05, Vol.24 (4), p.263-268

2002

Volltextzugriff (PDF)

Examination of Gene Fusion Status in Archival Samples of Alveolar Rhabdomyosarcoma Entered on the Intergroup Rhabdomyosarcoma Study-III Trial

The Journal of molecular diagnostics : JMD, 2006-05, Vol.8 (2), p.202-208

2006

Volltextzugriff (PDF)

Belief in home chemotherapy: Commentary on Stevens et al., page 285

Pediatric blood & cancer, 2006-09, Vol.47 (3), p.237-238

Breitfeld, Philip P.

2006

Volltextzugriff (PDF)

Web-based decision support for clinical trial eligibility determination in an international clinical trials network

Controlled clinical trials, 2003-12, Vol.24 (6), p.702-710

2003

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(45)
Buchkapitel
(1)

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(36)
Humans
(30)
Biological And Medical Sciences
(25)
Child
(22)
Oncology
(20)
Medical Sciences
(19)
Male
(15)
Female
(14)
Child, Preschool
(13)
Pediatrics
(13)
Hematology
(12)
Adolescent
(10)
Infant
(10)
Animals
(9)
Adult
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Rhabdomyosarcoma
(8)
Survival Analysis
(8)
Tumors
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group

Rhabdomyosarcoma: New Windows of Opportunity

Factors Associated with Failure of Oncology Drugs in Late-Stage Clinical Development: a Systematic Review

Assessment of Response to Induction Therapy and Its Influence on 5-Year Failure-Free Survival in Group III Rhabdomyosarcoma: The Intergroup Rhabdomyosarcoma Study-IV Experience—A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Pooled Analysis of Phase II Window Studies in Children With Contemporary High-Risk Metastatic Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group

End points to establish the efficacy of new agents in the treatment of acute leukemia

Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma

DOES BLADDER PRESERVATION (AS A SURGICAL PRINCIPLE) LEAD TO RETAINING BLADDER FUNCTION IN BLADDER/PROSTATE RHABDOMYOSARCOMA? RESULTS FROM INTERGROUP RHABDOMYOSARCOMA STUDY IV

Risk‐based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group

Efficacy of Topotecan and Cyclophosphamide Given in a Phase II Window Trial in Children With Newly Diagnosed Metastatic Rhabdomyosarcoma: A Children’s Oncology Group Study

Examination of Gene Fusion Status in Archival Samples of Alveolar Rhabdomyosarcoma Entered on the Intergroup Rhabdomyosarcoma Study-III Trial: A Report from the Children's Oncology Group

Belief in home chemotherapy

Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma children's cancer group (CCG) 7943

Hospital resource utilization in childhood cancer

Early Introduction of an Evidence‐based Medicine Course to Preclinical Medical Students

Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma

Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group

Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia

Assessing the overall impact of therapy: it's not so simple

Phosphorylation of the Polymeric Immunoglobulin Receptor Required for Its Efficient Transcytosis

Accurate case finding using linked electronic clinical and administrative data at a children's hospital

Modeling administrative outcomes in fever and neutropenia: clinical variables significantly influence length of stay and hospital charges

Examination of Gene Fusion Status in Archival Samples of Alveolar Rhabdomyosarcoma Entered on the Intergroup Rhabdomyosarcoma Study-III Trial

Belief in home chemotherapy: Commentary on Stevens et al., page 285

Web-based decision support for clinical trial eligibility determination in an international clinical trials network

Suchergebnisse filtern